Insider Transactions in Q3 2024 at Trevi Therapeutics, Inc. (TRVI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 09
2024
|
Jennifer L Good President & CEO |
SELL
Open market or private sale
|
Direct |
1,840
-0.86%
|
$5,520
$3.04 P/Share
|
|
Sep 09
2024
|
Jennifer L Good President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,840
+0.85%
|
$1,840
$1.43 P/Share
|
|
Sep 06
2024
|
Jennifer L Good President & CEO |
SELL
Open market or private sale
|
Direct |
4,219
-1.94%
|
$12,657
$3.03 P/Share
|
|
Sep 06
2024
|
Jennifer L Good President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,219
+1.9%
|
$4,219
$1.43 P/Share
|
|
Sep 05
2024
|
Jennifer L Good President & CEO |
SELL
Open market or private sale
|
Direct |
40,277
-15.88%
|
$120,831
$3.11 P/Share
|
|
Sep 05
2024
|
Jennifer L Good President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
40,277
+13.71%
|
$40,277
$1.43 P/Share
|
|
Sep 04
2024
|
Jennifer L Good President & CEO |
SELL
Open market or private sale
|
Direct |
10,981
-4.9%
|
$32,943
$3.02 P/Share
|
|
Sep 04
2024
|
Jennifer L Good President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,981
+4.67%
|
$10,981
$1.43 P/Share
|
|
Sep 03
2024
|
Jennifer L Good President & CEO |
SELL
Open market or private sale
|
Direct |
3,863
-1.78%
|
$11,589
$3.02 P/Share
|
|
Sep 03
2024
|
Jennifer L Good President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,863
+1.75%
|
$3,863
$1.43 P/Share
|
|
Aug 27
2024
|
David P Meeker |
SELL
Open market or private sale
|
Direct |
4,555
-1.28%
|
$9,110
$2.93 P/Share
|
|
Aug 27
2024
|
David P Meeker |
BUY
Exercise of conversion of derivative security
|
Direct |
4,555
+1.26%
|
$4,555
$1.43 P/Share
|
|
Aug 19
2024
|
Thomas Sciascia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
16,496
-6.97%
|
$32,992
$2.96 P/Share
|
|
Aug 19
2024
|
Thomas Sciascia Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,496
+6.51%
|
$16,496
$1.43 P/Share
|
|
Aug 16
2024
|
Thomas Sciascia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
18,660
-7.81%
|
$37,320
$2.76 P/Share
|
|
Aug 16
2024
|
Thomas Sciascia Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,660
+7.24%
|
$18,660
$1.43 P/Share
|
|
Aug 15
2024
|
Thomas Sciascia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,745
-5.47%
|
$25,490
$2.79 P/Share
|
|
Aug 15
2024
|
Thomas Sciascia Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,745
+5.19%
|
$12,745
$1.43 P/Share
|
|
Aug 14
2024
|
Thomas Sciascia Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
100
-0.05%
|
$200
$2.75 P/Share
|
|
Aug 14
2024
|
Thomas Sciascia Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.05%
|
$100
$1.43 P/Share
|